Skip to main content

Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease Profile

This is a publication on the Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease Profile in England: Incidence, mortality, stage and survival for ovary, fallopian tube and primary peritoneal carcinomas.

Current Chapter

Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease Profile


Summary

This is a publication on the Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease Profile in England: Incidence, mortality, stage and survival for ovary, fallopian tube and primary peritoneal carcinomas.


Highlights

The first report from the Ovarian Cancer Audit Feasibility Pilot was the Disease Profile, covering incidence, mortality, stage and survival, published January 2020.

Main findings:

  • the incidence rate of ovary, fallopian tube and primary peritoneal carcinomas in England has remained reasonably stable since 2001
  • incidence and mortality rates vary among CCGs and Cancer Alliances, with variation beyond what might be expected by random chance, suggesting that there may be genuine differences between areas
  • the proportions of patients diagnosed at early and late stages vary considerably around the country; some of this variability is likely due to data completeness but other factors should also be considered
  • completeness of stage data varies by geography; there is some room for improvement which would lead to better data quality for reporting
  • survival of patients with ovary, fallopian tube and primary peritoneal carcinomas has been improving since 2001. Improving one-year survival may reflect progress in diagnosing the disease sooner, with increased awareness of the symptoms amongst women and primary care practitioners, and improved diagnostic pathways, enabling more women to be diagnosed while still well enough to undergo treatment. Increased 5-year survival may reflect improvements in surgical and chemotherapy treatments. Assessment of geographic variation in survival rates may help to identify areas of best practice and improve the outlook for all patients

Last edited: 16 January 2023 2:01 pm